5 Results for "

NF-κB-IN-5

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "NF-κB-IN-5" in MCE Product Catalog:

Cat. No.: HY-147682
CAS No.: 2425675-52-9
Target:  

NF-κB Apoptosis

Research Areas:  

Cancer

NF-κB-IN-5 (compound 4d) is an orally active and potent NF-κB inhibitor by interacting directly with NF-κB. NF-κB-IN-5 shows antitumor activity against human cancer cell lines (HCT116, U87-MG, HepG2, BGC823, PC9), with IC50 values of 5.35, 2.81, 2.83, 2.02 and 3.90 μM, respectively. NF-κB-IN-5 induces apoptosis in U87-MG tumor cell and cell cycle arrest in G0/G1 phase .
loading...
    loading...
44
44 Cited Publications
Cat. No.: HY-15027
CAS No.: 89-57-6
Purity:  99.97%
Synonyms: MesalamINe; 5-ASA; MesalazINe
5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN).
loading...
    loading...
Cat. No.: HY-15027R
CAS No.: 89-57-6
Synonyms: MesalamINe (Standard); 5-ASA (Standard); MesalazINe (Standard)
5-Aminosalicylic Acid (Standard) is the analytical standard of 5-Aminosalicylic Acid. This product is intended for research and analytical applications. 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN).
loading...
    loading...
Cat. No.: HY-15027S4
Synonyms: 5-ASA-d7; Mesalamie-d7; Mesalazie-d7
5-Aminosalicylic acid-d7 (5-ASA-d7; Mesalamie-d7; Mesalazie-d7) is deuterium labeled 5-Aminosalicylic Acid. 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN) .
loading...
    loading...
Cat. No.: HY-Y0793
CAS No.: 3970-35-2
Target:  

Drug Intermediate

Research Areas:  

Inflammation/Immunology

Mesalazine impurity 2 is an impurity of Mesalazine (HY-15027). 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN).
loading...
    loading...